Q2 2015 13F Holders as of 6/30/2015
-
Type / Class
-
Equity / American Depositary Shares, each representing 1 Ordinary Shares
-
Shares outstanding
-
100M
-
Number of holders
-
40
-
Total 13F shares, excl. options
-
6.6M
-
Shares change
-
+477K
-
Total reported value, excl. options
-
$238M
-
Value change
-
+$18.4M
-
Number of buys
-
27
-
Number of sells
-
-23
-
Price
-
$36.08
Significant Holders of Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares (CLLS) as of Q2 2015
57 filings reported holding CLLS - Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares as of Q2 2015.
Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares (CLLS) has 40 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.6M shares
of 100M outstanding shares and own 6.58% of the company stock.
Largest 10 shareholders include FMR LLC (3.5M shares), ORBIMED ADVISORS LLC (350K shares), BlackRock Advisors LLC (305K shares), JPMORGAN CHASE & CO (300K shares), FRANKLIN RESOURCES INC (245K shares), LAZARD ASSET MANAGEMENT LLC (197K shares), Hudson Bay Capital Management LP (192K shares), PERCEPTIVE ADVISORS LLC (182K shares), GLG LLC (178K shares), and PICTON MAHONEY ASSET MANAGEMENT (139K shares).
This table shows the top 40 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.